Tutorial: best practices and considerations for mass-spectrometry-based protein biomarker discovery and validation

ES Nakayasu, M Gritsenko, PD Piehowski, Y Gao… - Nature …, 2021 - nature.com
Mass-spectrometry-based proteomic analysis is a powerful approach for discovering new
disease biomarkers. However, certain critical steps of study design such as cohort selection …

Cancer biomarker detection: recent achievements and challenges

L Wu, X Qu - Chemical Society Reviews, 2015 - pubs.rsc.org
The early detection of cancer can significantly reduce cancer mortality and saves lives. Thus,
a great deal of effort has been devoted to the exploration of new technologies to detect early …

Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities

S Vasaikar, C Huang, X Wang, VA Petyuk, SR Savage… - Cell, 2019 - cell.com
We performed the first proteogenomic study on a prospectively collected colon cancer
cohort. Comparative proteomic and phosphoproteomic analysis of paired tumor and normal …

Protein analysis by shotgun/bottom-up proteomics

Y Zhang, BR Fonslow, B Shan, MC Baek… - Chemical …, 2013 - ACS Publications
According to Genome Sequencing Project statistics (http://www. ncbi. nlm. nih.
gov/genomes/static/gpstat. html), as of February 16, 2012, complete gene sequences have …

Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach

SA Carr, SE Abbatiello, BL Ackermann… - Molecular & Cellular …, 2014 - ASBMB
Adoption of targeted mass spectrometry (MS) approaches such as multiple reaction
monitoring (MRM) to study biological and biomedical questions is well underway in the …

Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry

MA Gillette, SA Carr - Nature methods, 2013 - nature.com
Targeted mass spectrometry (MS) is becoming widely used in academia and in
pharmaceutical and biotechnology industries for sensitive and quantitative detection of …

Multi-scale signaling and tumor evolution in high-grade gliomas

J Liu, S Cao, KJ Imbach, MA Gritsenko, TSM Lih… - Cancer cell, 2024 - cell.com
Although genomic anomalies in glioblastoma (GBM) have been well studied for over a
decade, its 5-year survival rate remains lower than 5%. We seek to expand the molecular …

Clinical potential of mass spectrometry-based proteogenomics

B Zhang, JR Whiteaker, AN Hoofnagle… - Nature Reviews …, 2019 - nature.com
Cancer genomics research aims to advance personalized oncology by finding and targeting
specific genetic alterations associated with cancers. In genome-driven oncology, treatments …

Advances in targeted proteomics and applications to biomedical research

T Shi, E Song, S Nie, KD Rodland, T Liu, WJ Qian… - …, 2016 - Wiley Online Library
Targeted proteomics technique has emerged as a powerful protein quantification tool in
systems biology, biomedical research, and increasing for clinical applications. The most …

Single-molecule detection of protein efflux from microorganisms using fluorescent single-walled carbon nanotube sensor arrays

MP Landry, H Ando, AY Chen, J Cao… - Nature …, 2017 - nature.com
A distinct advantage of nanosensor arrays is their ability to achieve ultralow detection limits
in solution by proximity placement to an analyte. Here, we demonstrate label-free detection …